Literature DB >> 25701254

Novel tail and head group prostamide probes.

David F Finnegan1, Erin L Shelnut1, Spyros P Nikas1, Nan Chiang2, Charles N Serhan2, Alexandros Makriyannis3.   

Abstract

We report the design and synthesis of novel prostaglandin-ethanolamide (PGE2-EA) analogs containing head and tail group modifications to aid in the characterization of a putative prostamide receptor(s). Our synthetic approach utilizes Horner-Wadsworth-Emmons and Wittig reactions to construct the head and the tail moieties of the key PGE2 precursor, which leads to the final products through a peptide coupling, Swern oxidation and HF/pyridine assisted desilylation. The synthesized analogs were shown not to interact significantly with endocannabinoid proteins and recombinant EP1, EP3 and EP4 receptors and suggest a yet to be identified prostamide receptor as their site(s) of action.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cyclooxygenase-2; Endocannabinoids; Prostamides

Mesh:

Substances:

Year:  2015        PMID: 25701254      PMCID: PMC4405029          DOI: 10.1016/j.bmcl.2015.01.064

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  29 in total

1.  Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides.

Authors:  B F Cravatt; D K Giang; S P Mayfield; D L Boger; R A Lerner; N B Gilula
Journal:  Nature       Date:  1996-11-07       Impact factor: 49.962

2.  A second fatty acid amide hydrolase with variable distribution among placental mammals.

Authors:  Binqing Q Wei; Tarjei S Mikkelsen; Michele K McKinney; Eric S Lander; Benjamin F Cravatt
Journal:  J Biol Chem       Date:  2006-10-02       Impact factor: 5.157

3.  Stereospecific total synthesis of prostaglandins E3 and F3 alpha.

Authors:  E J Corey; H Shirahama; H Yamamoto; S Terashima; A Venkateswarlu; T K Schaaf
Journal:  J Am Chem Soc       Date:  1971-03-24       Impact factor: 15.419

4.  Head group analogs of arachidonylethanolamide, the endogenous cannabinoid ligand.

Authors:  A D Khanolkar; V Abadji; S Lin; W A Hill; G Taha; K Abouzid; Z Meng; P Fan; A Makriyannis
Journal:  J Med Chem       Date:  1996-10-25       Impact factor: 7.446

5.  Synthesis of prostaglandin E2 ethanolamide from anandamide by cyclooxygenase-2.

Authors:  M Yu; D Ives; C S Ramesha
Journal:  J Biol Chem       Date:  1997-08-22       Impact factor: 5.157

6.  Pharmacological characterization of a novel antiglaucoma agent, Bimatoprost (AGN 192024).

Authors:  D F Woodward; A H-P Krauss; J Chen; Y Liang; C Li; C E Protzman; A Bogardus; R Chen; K M Kedzie; H A Krauss; D W Gil; A Kharlamb; L A Wheeler; D Babusis; D Welty; D D-S Tang-Liu; M Cherukury; S W Andrews; R M Burk; M E Garst
Journal:  J Pharmacol Exp Ther       Date:  2003-01-24       Impact factor: 4.030

7.  Stereodivergent synthesis of all 15-F(2) isoprostanes.

Authors:  Thomas O Schrader; Marc L Snapper
Journal:  J Am Chem Soc       Date:  2002-09-18       Impact factor: 15.419

8.  Synthesis and biological activity of carboxyl-terminus modified prostaglandin analogues.

Authors:  T K Schaaf; H J Hess
Journal:  J Med Chem       Date:  1979-11       Impact factor: 7.446

9.  Amide and i-amino derivatives of F prostaglandins as prostaglandin antagonists.

Authors:  Y T Maddox; P W Ramwell; C S Shiner; E J Corey
Journal:  Nature       Date:  1978-06-15       Impact factor: 49.962

10.  Prostaglandin ethanolamides (prostamides): in vitro pharmacology and metabolism.

Authors:  I Matias; J Chen; L De Petrocellis; T Bisogno; A Ligresti; F Fezza; A H-P Krauss; L Shi; C E Protzman; C Li; Y Liang; A L Nieves; K M Kedzie; R M Burk; V Di Marzo; D F Woodward
Journal:  J Pharmacol Exp Ther       Date:  2004-02-02       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.